title: Vemurafenib-induced hypertension: is it real?
authors.affiliation: Departmant of Medical Oncology, Gaziantep University School of Medicine, Gaziantep, Turkey.
authors.forename: O
authors.initials: O
authors.lastname: Balakan
authors.forename: T
authors.initials: T
authors.lastname: Babacan
authors.forename: K
authors.initials: K
authors.lastname: Altundag
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D006801:Humans; D006973:Hypertension / Q000139:chemically induced* / Q000503:physiopathology; D007211:Indoles / Q000009:adverse effects*; D008545:Melanoma / Q000188:drug therapy*; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*; D012307:Risk Factors; D012878:Skin Neoplasms / Q000188:drug therapy*; D013449:Sulfonamides / Q000009:adverse effects*; D000077484:Vemurafenib
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D047428:Protein Kinase Inhibitors; D013449:Sulfonamides; D000077484:Vemurafenib